140 related articles for article (PubMed ID: 37478545)
1. Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as α-glucosidase inhibitors.
Basri R; Ullah S; Khan A; Mali SN; Abchir O; Chtita S; El-Gokha A; Taslimi P; Binsaleh AY; El-Kott AF; Al-Harrasi A; Shafiq Z
Bioorg Chem; 2023 Oct; 139():106739. PubMed ID: 37478545
[TBL] [Abstract][Full Text] [Related]
2. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel coumarin-based thiosemicarbazones and their implications in diabetic management via in-vitro and in-silico approaches.
Zahra SB; Ullah S; Halim SA; Waqas M; Huda NU; Khan A; Binsaleh AY; El-Kott AF; Hussain J; Al-Harrasi A; Shafiq Z
Sci Rep; 2023 Oct; 13(1):18014. PubMed ID: 37865657
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and molecular docking study of chromen-linked hydrazine carbothioamides as potent α-glucosidase inhibitors.
Basri R; Ullah S; Halim SA; Alharthy RD; Rauf U; Khan A; Hussain J; Al-Ghafri A; Al-Harrasi A; Shafiq Z
Drug Dev Res; 2023 Aug; 84(5):962-974. PubMed ID: 37186392
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new phenoxymethylcoumarin clubbed 4-arylthiazolylhydrazines as α-glucosidase inhibitors and their kinetics and molecular docking studies.
Ul Ain Q; Saeed A; Khan A; Ahmed A; Ullah S; Ahsan Halim S; Irfan M; Tehzeeb A; El-Seedi HR; Bin Muhsinah A; Al-Harrasi A
Bioorg Chem; 2023 Feb; 131():106302. PubMed ID: 36528921
[TBL] [Abstract][Full Text] [Related]
6. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
[TBL] [Abstract][Full Text] [Related]
7. Novel Bis-Schiff's base derivatives of 4-nitroacetophenone as potent α-glucosidase agents: Design, synthesis and in silico approach.
Alam A; Ali M; Latif A; Rehman NU; Saher S; Zainab ; Faryal ; Khan A; Ullah S; Ullah O; Halim SA; Sani F; Al-Harrasi A; Ahmad M
Bioorg Chem; 2022 Nov; 128():106058. PubMed ID: 35917750
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors.
Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W
Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754
[TBL] [Abstract][Full Text] [Related]
9. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
Phongphane L; Mohd Radzuan SN; Abu Bakar MH; Che Omar MT; Supratman U; Harneti D; A Wahab H; Azmi MN
Comput Biol Chem; 2023 Oct; 106():107938. PubMed ID: 37542847
[TBL] [Abstract][Full Text] [Related]
11. Coumarin linked to 2-phenylbenzimidazole derivatives as potent α-glucosidase inhibitors.
Ganjeh MS; Mazlomifar A; Shahvelayti AS; Moghaddam SK
Sci Rep; 2024 Mar; 14(1):7408. PubMed ID: 38548784
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
14. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
15. Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies.
Kausar N; Ullah S; Khan MA; Zafar H; Atia-Tul-Wahab ; Choudhary MI; Yousuf S
Bioorg Chem; 2021 Jan; 106():104499. PubMed ID: 33288319
[TBL] [Abstract][Full Text] [Related]
16. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 3-hydroxy-2-naphthohydrazide-based hydrazones and their implications in diabetic management via in vitro and in silico approaches.
Tasleem M; Ullah S; Halim SA; Urooj I; Ahmed N; Munir R; Khan A; El-Kott AF; Taslimi P; Negm S; Al-Harrasi A; Shafiq Z
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300544. PubMed ID: 38013251
[TBL] [Abstract][Full Text] [Related]
18. Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling.
Rehman TU; Riaz S; Khan IU; Ashraf M; Bajda M; Gawalska A; Yar M
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29194730
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
Wang G; Chen M; Qiu J; Xie Z; Cao A
Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
